Compounds Screening/Testing TRIZ Cases

Gastrointestinal lavage fluid enables non-invasive pancreatic cancer detection by replacing invasive biopsies with biochemical analysis of collected fluids.

Culturing 3D lung cancer organoids using specific growth factors and Matrigel substrates to establish patient-derived xenograft models.

Corroles bond to metal oxide surfaces via sulfonate linkages, enabling targeted optical imaging with minimal cytotoxicity.

A neutron capture therapy system uses a specific compound to target and destroy amyloid beta-protein structures.

ZIF-8 encapsulation maintains mitochondrial bioactivity at room temperature for three weeks, resolving storage duration versus stability trade-offs.

Spectrophotometric colorimetry replaces invasive diagnostics by measuring skin redness shifts during exercise, enabling early detection of vascular disease.

Anti-IL-6 antibodies bind human IL-6 to lower C-reactive protein and raise serum albumin, addressing adverse reactions from current therapies.

Genetically modified animals expressing human CD3e proteins enable precise evaluation of anti-human antibodies and cancer therapies.

Segmenting antibody and T-cell detection resolves low sensitivity in seropositive populations, enabling precise congenital infection risk assessment.

Measuring central ear artery lumen diameter in rabbits via ultrasonic imaging to assess vasomotor responses.

A swellable microprotrusion array absorbs interstitial fluid from skin to recover and quantify microRNA without invasive tissue removal.

A single LED radiation source paired with a photodiode detector unit measures electromagnetic remission for protection factor analysis.

Aptamer-particle conjugates bind target analytes to generate a detectable response signal for non-invasive physiological monitoring.

NTS-polyplex nanoparticles deliver BDNF genes to dopaminergic neurons via neurotensin receptors, resolving viral vector safety and specificity trade-offs.

INT131 PPARγ agonist targets neuroinflammation and oxidative stress to slow brain degeneration in progressive supranuclear palsy.

A humanized Cxcl13 gene in rodents overcomes insufficient human cell survival in conventional models, enabling accurate therapeutic testing.

COS-7 cells expressing human oncostatin M resolve murine model limitations by providing functional homology for accurate reactivity evaluation.

A genetically engineered mouse model expresses mutant PIK3CA from its native promoter using Cre-mediated recombination.

Transgenic animals expressing interacting human proteins enable precise therapeutic agent screening.

Multivalent affinity reagent constructs detect analytes in vivo, eliminating blood sample collection and reducing turnaround time for point-of-care testing.

Antibodies targeting IL-13RA2 address limited specificity in glioblastoma therapy.

A transgenic mouse model uses a p16INK4a promoter to drive expression of fluorescent or cytotoxic proteins specifically within senescent cells.

PEGylated hydrocyanine dyes normalize fluorescent signals to correct variable dye delivery and improve measurement precision.

Endogenous human interleukin 15 expression eliminates repeated recombinant injections while maintaining functional natural killer cells for anti-tumor testing.

Novel 110 kDa Dermatophagoides farinae protein binds serum IgE to activate basophils, addressing limited patient coverage in existing mite immunotherapies.

IL-10 mediates cholesterol reduction by enhancing Kupffer cell lipid clearance, avoiding adverse effects of conventional agents.

Defined viscosity profiles standardize texture assessment, resolving inconsistent diagnosis reliability and reducing aspiration risk.

Anti-CTGF antibodies inhibit connective tissue growth factor to reverse pulmonary decline, extending survival where conventional therapies fail.

Replacing mouse gene sequences with human counterparts resolves sequence mismatch issues, improving preclinical drug screening reliability.

A bioprinted human stromal microenvironment replicates native tissue architecture to enable precise cellular engraftment and proliferation measurements.

Glutathione-coated gold nanoparticles enable noninvasive kidney functional imaging via near-infrared fluorescence detection.

Intravitreal sodium iodate injection creates accurate macular atrophy models, resolving systemic toxicity trade-offs.

Replacing benzodiazepines with optogenetic BLA targeting eliminates addiction risks while providing immediate, reliable anxiety modulation.

Targeted mutations in nonessential genes reduce viral pathogenicity while preserving replication competence, bypassing time-consuming iterative passage methods.

Natalizumab therapy manages progressive multifocal leukoencephalopathy risk through JC virus antibody screening and symptom monitoring.

A urushiol-containing epicutaneous patch test system quantifies dermatitis severity and dose-response relationships.

Intralipid lipid microparticles enhance Doppler frequency shifts to detect capillary blood flow velocity in highly scattering media.

A peptide with specific amino acid sequence binds to irradiated colorectal cancer tissues for targeted diagnosis and drug delivery.

An in vivo animal model assesses therapeutic response by blocking IgE binding, preventing severe adverse events during treatment.

Correcting the Hc gene deletion restores complement-dependent cytotoxicity in immunodeficient NSG mice, enabling in vivo assessment of anti-cancer therapeutics.

A single-point breath test using a 13C-labeled meal to diagnose gastric emptying.

Oxidant compositions deactivate urushiol allergens through chemical conversion, resolving inadequate removal by standard soaps.

Inhibiting Kir4.1 channels in lateral habenula astrocytes reduces abnormal neuronal firing, addressing the slow onset of conventional antidepressants.

Fah-deficient pigs host transplanted human hepatocytes to overcome limited culture expansion and provide a large animal model for liver diseases.

Optimized monoclonal antibodies target the HIV-1 gp41 membrane-proximal external region, resolving limited strain cross-reactivity in existing vaccines.

Engineered antibodies bind amyloid beta oligomers using specific complementarity determining regions to inhibit toxic aggregation and propagation.

Human cytokine expression in immunodeficient mice enables accurate sickle cell disease modeling by supporting human red blood cell production.